| JUPITER, Fla., March 27, 2012 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the year ended December 31, 2011. The financial information contained in this press release should be read in conjunction with the audited financial statements, footnotes and independe...continued DYAI biotech enzyme production |
Tuesday, March 27, 2012
Dyadic International Reports 2011 Fiscal Year Financial Results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment